Current Role of Autologous and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma

Classical Hodgkin lymphoma (cHL) is a relatively rare disease, with approximately 9,200 estimated new cases and 1,200 estimated deaths per year in the United States. First-line chemo-radiotherapy leads to cure rates approaching 80% in patients with advanced-stage disease. However, 25 to 30% of these...

Descripción completa

Detalles Bibliográficos
Autores principales: Castagna, Luca, Carlo-Stella, Carmelo, Mazza, Rita, Santoro, Armando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344175/
https://www.ncbi.nlm.nih.gov/pubmed/25745542
http://dx.doi.org/10.4084/MJHID.2015.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344175/
https://www.ncbi.nlm.nih.gov/pubmed/25745542
http://dx.doi.org/10.4084/MJHID.2015.015

Ejemplares similares